0 |
ADULTERATED PRODUCT |
14 |
0.1591 |
1 |
ARACHNOPHOBIA |
1 |
0.1111 |
2 |
HAIR PLUCKING |
2 |
0.1000 |
3 |
DISRUPTIVE MOOD DYSREGULATION DISORDER |
3 |
0.0577 |
4 |
NAIL PICKING |
2 |
0.0526 |
5 |
ALCALIGENES INFECTION |
1 |
0.0500 |
6 |
ADRENOLEUKODYSTROPHY |
1 |
0.0476 |
7 |
ACCESSORY CARDIAC PATHWAY |
1 |
0.0455 |
8 |
ACQUIRED EPILEPTIC APHASIA |
1 |
0.0417 |
9 |
AUDIOGRAM ABNORMAL |
1 |
0.0312 |
10 |
SOMATIC SYMPTOM DISORDER |
19 |
0.0222 |
11 |
INTELLIGENCE TEST ABNORMAL |
2 |
0.0196 |
12 |
CLAUSTROPHOBIA |
18 |
0.0195 |
13 |
ARCUS LIPOIDES |
1 |
0.0192 |
14 |
SEXUAL ACTIVITY INCREASED |
2 |
0.0180 |
15 |
TOURETTE'S DISORDER |
4 |
0.0176 |
16 |
OPPOSITIONAL DEFIANT DISORDER |
6 |
0.0172 |
17 |
CHANGE IN SUSTAINED ATTENTION |
3 |
0.0151 |
18 |
AMINO ACID LEVEL ABNORMAL |
1 |
0.0149 |
19 |
PRODUCT TAMPERING |
15 |
0.0144 |
20 |
HAND-EYE COORDINATION IMPAIRED |
2 |
0.0144 |
21 |
CAPSULE PHYSICAL ISSUE |
2 |
0.0138 |
22 |
EDUCATIONAL PROBLEM |
20 |
0.0131 |
23 |
ASPERGER'S DISORDER |
1 |
0.0125 |
24 |
TIC |
57 |
0.0121 |
25 |
DEFIANT BEHAVIOUR |
2 |
0.0120 |
26 |
BONE DEVELOPMENT ABNORMAL |
3 |
0.0119 |
27 |
ADRENAL CYST |
1 |
0.0116 |
28 |
PRODUCT CONTAMINATION CHEMICAL |
2 |
0.0115 |
29 |
ADHESIVE TAPE USE |
2 |
0.0114 |
30 |
BODY HEIGHT INCREASED |
3 |
0.0114 |
31 |
BACTERIA URINE |
1 |
0.0104 |
32 |
ALKALOSIS HYPOCHLORAEMIC |
1 |
0.0103 |
33 |
CROUP INFECTIOUS |
6 |
0.0103 |
34 |
PULSE ABNORMAL |
20 |
0.0103 |
35 |
AMPHETAMINES POSITIVE |
6 |
0.0086 |
36 |
ANTISOCIAL PERSONALITY DISORDER |
1 |
0.0086 |
37 |
AUTISM |
8 |
0.0079 |
38 |
HYPERMETABOLISM |
3 |
0.0078 |
39 |
BOREDOM |
2 |
0.0070 |
40 |
GROWTH RETARDATION |
17 |
0.0069 |
41 |
DERMATILLOMANIA |
3 |
0.0065 |
42 |
RAYNAUD'S PHENOMENON |
6 |
0.0064 |
43 |
DISTRACTIBILITY |
6 |
0.0063 |
44 |
SOCIAL ANXIETY DISORDER |
3 |
0.0063 |
45 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
13 |
0.0060 |
46 |
HYPERREFLEXIA |
18 |
0.0059 |
47 |
CLUBBING |
2 |
0.0058 |
48 |
NEGATIVISM |
4 |
0.0057 |
49 |
BLUNTED AFFECT |
3 |
0.0057 |
50 |
ANTISOCIAL BEHAVIOUR |
5 |
0.0056 |
51 |
DRUG WITHDRAWAL HEADACHE |
2 |
0.0056 |
52 |
ANOVULATORY CYCLE |
1 |
0.0055 |
53 |
CATAPLEXY |
7 |
0.0055 |
54 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
9 |
0.0054 |
55 |
OCULAR NEOPLASM |
2 |
0.0052 |
56 |
BELLIGERENCE |
2 |
0.0050 |
57 |
ADMINISTRATION SITE ERYTHEMA |
1 |
0.0049 |
58 |
IMPULSIVE BEHAVIOUR |
15 |
0.0048 |
59 |
EXCESSIVE EYE BLINKING |
6 |
0.0047 |
60 |
SYSTEMIC SCLERODERMA |
2 |
0.0047 |
61 |
AUTISM SPECTRUM DISORDER |
11 |
0.0045 |
62 |
GRIMACING |
3 |
0.0044 |
63 |
OPIATES POSITIVE |
2 |
0.0044 |
64 |
ABNORMAL BEHAVIOUR |
153 |
0.0043 |
65 |
NEUROLOGICAL SYMPTOM |
19 |
0.0042 |
66 |
HEAD BANGING |
2 |
0.0042 |
67 |
ADMINISTRATION SITE BRUISE |
1 |
0.0041 |
68 |
CATHETER SITE PRURITUS |
3 |
0.0040 |
69 |
ADMINISTRATION SITE SWELLING |
1 |
0.0039 |
70 |
TRICHOTILLOMANIA |
2 |
0.0039 |
71 |
LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR |
2 |
0.0038 |
72 |
PSYCHOMOTOR HYPERACTIVITY |
55 |
0.0038 |
73 |
ASTHMA EXERCISE INDUCED |
1 |
0.0037 |
74 |
ADENOIDECTOMY |
1 |
0.0036 |
75 |
LEARNING DISORDER |
4 |
0.0035 |
76 |
PSYCHOTIC BEHAVIOUR |
3 |
0.0035 |
77 |
WEIGHT GAIN POOR |
6 |
0.0034 |
78 |
ANOMALY OF EXTERNAL EAR CONGENITAL |
1 |
0.0034 |
79 |
PAINFUL ERECTION |
2 |
0.0032 |
80 |
PSEUDOMONAS TEST POSITIVE |
2 |
0.0031 |
81 |
PERFORMANCE STATUS DECREASED |
12 |
0.0031 |
82 |
AGGRESSION |
130 |
0.0030 |
83 |
VASOCONSTRICTION |
2 |
0.0030 |
84 |
SOLILOQUY |
2 |
0.0030 |
85 |
PRE-EXISTING CONDITION IMPROVED |
17 |
0.0029 |
86 |
DISTURBANCE IN ATTENTION |
133 |
0.0029 |
87 |
ANGER |
85 |
0.0029 |
88 |
ALTERED VISUAL DEPTH PERCEPTION |
2 |
0.0029 |
89 |
PARANOIA |
42 |
0.0029 |
90 |
CARBON DIOXIDE INCREASED |
3 |
0.0028 |
91 |
EYE ROLLING |
2 |
0.0028 |
92 |
CLUSTER HEADACHE |
3 |
0.0028 |
93 |
ENURESIS |
9 |
0.0028 |
94 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
2 |
0.0028 |
95 |
BEHAVIOUR DISORDER |
9 |
0.0028 |
96 |
SIMPLE PARTIAL SEIZURES |
2 |
0.0027 |
97 |
CEREBRAL PALSY |
2 |
0.0027 |
98 |
DRUG EFFECT VARIABLE |
3 |
0.0026 |
99 |
SELF INJURIOUS BEHAVIOUR |
8 |
0.0026 |
100 |
UNDERWEIGHT |
4 |
0.0026 |
101 |
NARCOLEPSY |
4 |
0.0026 |
102 |
BRUGADA SYNDROME |
2 |
0.0026 |
103 |
THERAPEUTIC RESPONSE CHANGED |
7 |
0.0025 |
104 |
ABDOMINAL INJURY |
1 |
0.0025 |
105 |
HALLUCINATIONS, MIXED |
8 |
0.0025 |
106 |
CONVERSION DISORDER |
4 |
0.0024 |
107 |
IMPULSE-CONTROL DISORDER |
4 |
0.0024 |
108 |
FOAMING AT MOUTH |
4 |
0.0024 |
109 |
ASYMPTOMATIC COVID-19 |
1 |
0.0024 |
110 |
SCREAMING |
12 |
0.0023 |
111 |
TINEA INFECTION |
2 |
0.0023 |
112 |
LOGORRHOEA |
7 |
0.0023 |
113 |
SOCIAL AVOIDANT BEHAVIOUR |
12 |
0.0023 |
114 |
SLEEP TERROR |
7 |
0.0023 |
115 |
BANKRUPTCY |
1 |
0.0023 |
116 |
BRAIN INJURY |
18 |
0.0022 |
117 |
DEVICE POWER SOURCE ISSUE |
3 |
0.0022 |
118 |
SUBSTANCE USE |
2 |
0.0022 |
119 |
PRODUCT MEASURED POTENCY ISSUE |
2 |
0.0022 |
120 |
DISINHIBITION |
3 |
0.0021 |
121 |
AMBLYOPIA |
1 |
0.0021 |
122 |
HOSTILITY |
5 |
0.0021 |
123 |
NEGATIVE THOUGHTS |
5 |
0.0021 |
124 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
10 |
0.0021 |
125 |
ADRENAL ADENOMA |
1 |
0.0020 |
126 |
ANGULAR CHEILITIS |
1 |
0.0020 |
127 |
GLUCOSE URINE PRESENT |
2 |
0.0020 |
128 |
BLADDER DISCOMFORT |
2 |
0.0020 |
129 |
INTERCEPTED DRUG DISPENSING ERROR |
3 |
0.0020 |
130 |
DRUG SCREEN NEGATIVE |
3 |
0.0020 |
131 |
MOOD SWINGS |
55 |
0.0020 |
132 |
CRYING |
63 |
0.0020 |
133 |
DENTAL CARE |
3 |
0.0020 |
134 |
ENERGY INCREASED |
10 |
0.0020 |
135 |
DEVICE INFORMATION OUTPUT ISSUE |
5 |
0.0019 |
136 |
DRUG TOLERANCE |
8 |
0.0019 |
137 |
SUICIDAL BEHAVIOUR |
7 |
0.0019 |
138 |
STARING |
4 |
0.0019 |
139 |
HYPERTENSIVE CRISIS |
18 |
0.0019 |
140 |
ATONIC SEIZURES |
1 |
0.0019 |
141 |
DYSPHEMIA |
7 |
0.0019 |
142 |
HOMICIDAL IDEATION |
7 |
0.0019 |
143 |
IRRITABILITY |
96 |
0.0019 |
144 |
PNEUMONIA STAPHYLOCOCCAL |
3 |
0.0018 |
145 |
OCULOGYRIC CRISIS |
3 |
0.0018 |
146 |
TERMINAL INSOMNIA |
2 |
0.0018 |
147 |
EMOTIONAL DISORDER |
48 |
0.0018 |
148 |
OBSESSIVE-COMPULSIVE DISORDER |
13 |
0.0018 |
149 |
PRODUCT SUBSTITUTION ISSUE |
89 |
0.0018 |
150 |
CATHETER SITE ERYTHEMA |
3 |
0.0018 |
151 |
EXOPHTHALMOS |
3 |
0.0018 |
152 |
PRODUCT PHYSICAL ISSUE |
27 |
0.0018 |
153 |
AFFECTIVE DISORDER |
11 |
0.0018 |
154 |
BIPOLAR DISORDER |
17 |
0.0018 |
155 |
BACTERIAL VAGINOSIS |
2 |
0.0018 |
156 |
ANXIETY DISORDER |
5 |
0.0018 |
157 |
AMINO ACID LEVEL INCREASED |
1 |
0.0018 |
158 |
ABNORMAL SLEEP-RELATED EVENT |
2 |
0.0017 |
159 |
GENERALISED ANXIETY DISORDER |
2 |
0.0017 |
160 |
ERECTION INCREASED |
7 |
0.0017 |
161 |
APPLICATION SITE INFLAMMATION |
2 |
0.0017 |
162 |
GYNAECOMASTIA |
50 |
0.0017 |
163 |
PRIAPISM |
5 |
0.0017 |
164 |
EXPIRED DEVICE USED |
3 |
0.0017 |
165 |
PRODUCT COLOUR ISSUE |
6 |
0.0017 |
166 |
BRAIN FOG |
2 |
0.0017 |
167 |
HYPERPHAGIA |
5 |
0.0017 |
168 |
DARK CIRCLES UNDER EYES |
2 |
0.0016 |
169 |
MYDRIASIS |
17 |
0.0016 |
170 |
BENIGN INTRACRANIAL HYPERTENSION |
2 |
0.0016 |
171 |
THROAT CLEARING |
4 |
0.0016 |
172 |
INITIAL INSOMNIA |
12 |
0.0016 |
173 |
DAYDREAMING |
2 |
0.0015 |
174 |
DRUG DIVERSION |
5 |
0.0015 |
175 |
BLEPHAROSPASM |
6 |
0.0015 |
176 |
CATHETER SITE HAEMORRHAGE |
3 |
0.0015 |
177 |
DEAFNESS BILATERAL |
2 |
0.0015 |
178 |
TONSILLECTOMY |
2 |
0.0015 |
179 |
CYSTITIS INTERSTITIAL |
2 |
0.0015 |
180 |
ALLERGIC REACTION TO EXCIPIENT |
2 |
0.0015 |
181 |
ILLUSION |
2 |
0.0015 |
182 |
FORMICATION |
9 |
0.0015 |
183 |
ROTATOR CUFF REPAIR |
2 |
0.0015 |
184 |
COSTOCHONDRITIS |
2 |
0.0015 |
185 |
PHARYNGITIS STREPTOCOCCAL |
12 |
0.0014 |
186 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0014 |
187 |
MOOD ALTERED |
32 |
0.0014 |
188 |
VIOLENCE-RELATED SYMPTOM |
2 |
0.0014 |
189 |
ALLERGY TO ANIMAL |
1 |
0.0014 |
190 |
PSYCHOTIC SYMPTOM |
2 |
0.0014 |
191 |
SOMNAMBULISM |
8 |
0.0014 |
192 |
INAPPROPRIATE AFFECT |
2 |
0.0014 |
193 |
RED BLOOD CELL COUNT INCREASED |
3 |
0.0014 |
194 |
WITHDRAWAL SYNDROME |
44 |
0.0014 |
195 |
BREAST ENLARGEMENT |
4 |
0.0014 |
196 |
BLADDER SPASM |
2 |
0.0014 |
197 |
PERSONALITY DISORDER |
3 |
0.0013 |
198 |
AMENORRHOEA |
19 |
0.0013 |
199 |
MUSCLE TWITCHING |
26 |
0.0013 |
200 |
PERSONALITY CHANGE |
11 |
0.0013 |
201 |
YAWNING |
3 |
0.0013 |
202 |
CRANIOCEREBRAL INJURY |
3 |
0.0013 |
203 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
0.0013 |
204 |
SNORING |
4 |
0.0013 |
205 |
CLUMSINESS |
3 |
0.0013 |
206 |
INABILITY TO AFFORD MEDICATION |
7 |
0.0013 |
207 |
HYPERAEMIA |
2 |
0.0013 |
208 |
PRODUCT LOT NUMBER ISSUE |
2 |
0.0013 |
209 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
2 |
0.0013 |
210 |
OBSESSIVE THOUGHTS |
2 |
0.0013 |
211 |
BLOOD PROLACTIN INCREASED |
5 |
0.0012 |
212 |
STRABISMUS |
3 |
0.0012 |
213 |
BLOOD CREATININE DECREASED |
3 |
0.0012 |
214 |
DEREALISATION |
2 |
0.0012 |
215 |
AMYOTROPHIC LATERAL SCLEROSIS |
2 |
0.0012 |
216 |
SUICIDAL IDEATION |
91 |
0.0012 |
217 |
EXCORIATION |
3 |
0.0012 |
218 |
DRUG DISPENSING ERROR |
18 |
0.0012 |
219 |
DECREASED INTEREST |
6 |
0.0012 |
220 |
SELF-INJURIOUS IDEATION |
4 |
0.0012 |
221 |
TONGUE BITING |
2 |
0.0012 |
222 |
LIVER INJURY |
18 |
0.0012 |
223 |
HALLUCINATION, AUDITORY |
15 |
0.0012 |
224 |
INCORRECT STORAGE OF DRUG |
2 |
0.0012 |
225 |
FEELING JITTERY |
19 |
0.0012 |
226 |
INSURANCE ISSUE |
7 |
0.0011 |
227 |
DRUG PRESCRIBING ERROR |
22 |
0.0011 |
228 |
WRONG PRODUCT ADMINISTERED |
5 |
0.0011 |
229 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
12 |
0.0011 |
230 |
PRODUCT AVAILABILITY ISSUE |
13 |
0.0011 |
231 |
BRUXISM |
5 |
0.0011 |
232 |
UPPER-AIRWAY COUGH SYNDROME |
7 |
0.0011 |
233 |
ASTERIXIS |
1 |
0.0011 |
234 |
PRESCRIBED OVERDOSE |
17 |
0.0011 |
235 |
ARTERIAL HAEMORRHAGE |
1 |
0.0011 |
236 |
STAPHYLOCOCCUS TEST POSITIVE |
2 |
0.0011 |
237 |
ACCIDENT AT WORK |
2 |
0.0011 |
238 |
OTITIS MEDIA |
3 |
0.0011 |
239 |
TEARFULNESS |
4 |
0.0011 |
240 |
COMPULSIVE SHOPPING |
2 |
0.0011 |
241 |
ACARODERMATITIS |
1 |
0.0011 |
242 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
39 |
0.0011 |
243 |
PARADOXICAL DRUG REACTION |
3 |
0.0011 |
244 |
EYE MOVEMENT DISORDER |
6 |
0.0011 |
245 |
PSYCHOTIC DISORDER |
26 |
0.0011 |
246 |
CYSTIC FIBROSIS |
5 |
0.0011 |
247 |
RETCHING |
18 |
0.0011 |
248 |
CATHETER SITE PAIN |
2 |
0.0011 |
249 |
DEPRESSION SUICIDAL |
3 |
0.0010 |
250 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
4 |
0.0010 |
251 |
AGITATION |
64 |
0.0010 |
252 |
HYPOPHAGIA |
20 |
0.0010 |
253 |
PRODUCT SIZE ISSUE |
4 |
0.0010 |
254 |
ADJUSTMENT DISORDER |
1 |
0.0010 |
255 |
MUSCLE CONTRACTIONS INVOLUNTARY |
3 |
0.0010 |
256 |
BREATH ODOUR |
2 |
0.0010 |
257 |
SLEEP APNOEA SYNDROME |
16 |
0.0010 |
258 |
PETIT MAL EPILEPSY |
4 |
0.0010 |
259 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
7 |
0.0010 |
260 |
ANKLE OPERATION |
1 |
0.0010 |
261 |
THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION |
4 |
0.0010 |
262 |
HYPOMANIA |
3 |
0.0010 |
263 |
AFFECT LABILITY |
8 |
0.0009 |
264 |
OEDEMA MOUTH |
3 |
0.0009 |
265 |
COMMUNICATION DISORDER |
3 |
0.0009 |
266 |
SKIN WRINKLING |
2 |
0.0009 |
267 |
ESSENTIAL HYPERTENSION |
2 |
0.0009 |
268 |
APPLICATION SITE IRRITATION |
10 |
0.0009 |
269 |
DEPRESSED MOOD |
39 |
0.0009 |
270 |
SOCIAL PROBLEM |
3 |
0.0009 |
271 |
BILIARY COLIC |
2 |
0.0009 |
272 |
OVERWEIGHT |
4 |
0.0009 |
273 |
HALLUCINATION, VISUAL |
15 |
0.0009 |
274 |
COELIAC DISEASE |
7 |
0.0009 |
275 |
FINE MOTOR SKILL DYSFUNCTION |
2 |
0.0009 |
276 |
TARDIVE DYSKINESIA |
24 |
0.0009 |
277 |
PRODUCT FORMULATION ISSUE |
5 |
0.0009 |
278 |
OBESITY |
11 |
0.0009 |
279 |
SELF ESTEEM DECREASED |
2 |
0.0009 |
280 |
DRUG LEVEL DECREASED |
7 |
0.0009 |
281 |
HYPERPROLACTINAEMIA |
5 |
0.0009 |
282 |
REBOUND EFFECT |
6 |
0.0009 |
283 |
MICTURITION URGENCY |
8 |
0.0009 |
284 |
FEAR |
21 |
0.0009 |
285 |
MAJOR DEPRESSION |
5 |
0.0009 |
286 |
TRICHORRHEXIS |
2 |
0.0009 |
287 |
VENTRICULAR HYPERTROPHY |
2 |
0.0009 |
288 |
HALLUCINATION |
50 |
0.0009 |
289 |
ABNORMAL WEIGHT GAIN |
10 |
0.0008 |
290 |
EATING DISORDER |
15 |
0.0008 |
291 |
RECALLED PRODUCT ADMINISTERED |
4 |
0.0008 |
292 |
FOOD ALLERGY |
4 |
0.0008 |
293 |
APPARENT DEATH |
3 |
0.0008 |
294 |
GALACTORRHOEA |
5 |
0.0008 |
295 |
DRUG EFFECT LESS THAN EXPECTED |
4 |
0.0008 |
296 |
CENTRAL VENOUS CATHETERISATION |
2 |
0.0008 |
297 |
FRUSTRATION TOLERANCE DECREASED |
5 |
0.0008 |
298 |
PANIC REACTION |
5 |
0.0008 |
299 |
APPETITE DISORDER |
4 |
0.0008 |
300 |
INCREASED APPETITE |
11 |
0.0008 |
301 |
CONCUSSION |
5 |
0.0008 |
302 |
APPLICATION SITE PRURITUS |
16 |
0.0008 |
303 |
CONVULSION |
46 |
0.0008 |
304 |
PRODUCT QUALITY ISSUE |
97 |
0.0008 |
305 |
MANIA |
11 |
0.0008 |
306 |
ILLNESS |
39 |
0.0008 |
307 |
APPLICATION SITE HAEMORRHAGE |
2 |
0.0008 |
308 |
PARKINSON'S DISEASE |
2 |
0.0008 |
309 |
POTENTIATING DRUG INTERACTION |
2 |
0.0008 |
310 |
RESTLESSNESS |
24 |
0.0008 |
311 |
DIABETIC COMA |
2 |
0.0008 |
312 |
TONGUE DISORDER |
5 |
0.0008 |
313 |
TENSION |
4 |
0.0008 |
314 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
2 |
0.0008 |
315 |
SCOLIOSIS |
4 |
0.0008 |
316 |
DYSTONIA |
13 |
0.0008 |
317 |
APPLICATION SITE ERYTHEMA |
18 |
0.0008 |
318 |
GRAND MAL CONVULSION |
7 |
0.0008 |
319 |
CYANOSIS |
10 |
0.0008 |
320 |
VULVOVAGINAL DRYNESS |
2 |
0.0008 |
321 |
CREPITATIONS |
2 |
0.0007 |
322 |
SUPRAVENTRICULAR TACHYCARDIA |
6 |
0.0007 |
323 |
DECREASED APPETITE |
133 |
0.0007 |
324 |
THINKING ABNORMAL |
12 |
0.0007 |
325 |
SUSPECTED COUNTERFEIT PRODUCT |
2 |
0.0007 |
326 |
PENILE PAIN |
2 |
0.0007 |
327 |
STREPTOCOCCAL INFECTION |
3 |
0.0007 |
328 |
TRISMUS |
3 |
0.0007 |
329 |
DYSKINESIA |
24 |
0.0007 |
330 |
FEELING ABNORMAL |
146 |
0.0007 |
331 |
GENERALISED ERYTHEMA |
4 |
0.0007 |
332 |
VISUAL DISTURBANCE |
4 |
0.0007 |
333 |
AMYLASE INCREASED |
2 |
0.0007 |
334 |
BLOOD PHOSPHORUS DECREASED |
2 |
0.0007 |
335 |
NON-CARDIAC CHEST PAIN |
2 |
0.0007 |
336 |
SUPRAVENTRICULAR EXTRASYSTOLES |
2 |
0.0007 |
337 |
TACHYPHRENIA |
2 |
0.0007 |
338 |
COLD SWEAT |
10 |
0.0007 |
339 |
EUPHORIC MOOD |
6 |
0.0007 |
340 |
ACUTE SINUSITIS |
1 |
0.0007 |
341 |
AUTOIMMUNE DISORDER |
4 |
0.0007 |
342 |
PRODUCT USE COMPLAINT |
6 |
0.0007 |
343 |
AURA |
1 |
0.0007 |
344 |
DRUG EFFECT DELAYED |
3 |
0.0007 |
345 |
HANGOVER |
2 |
0.0007 |
346 |
SEDATION |
13 |
0.0007 |
347 |
THERAPEUTIC RESPONSE UNEXPECTED |
25 |
0.0007 |
348 |
HYPERACUSIS |
2 |
0.0007 |
349 |
GLUCOSE TOLERANCE IMPAIRED |
3 |
0.0006 |
350 |
DRUG EFFECT DECREASED |
35 |
0.0006 |
351 |
APPLICATION SITE DISCOMFORT |
1 |
0.0006 |
352 |
TYPE 1 DIABETES MELLITUS |
3 |
0.0006 |
353 |
LETHARGY |
31 |
0.0006 |
354 |
DEPRESSION |
125 |
0.0006 |
355 |
DRUG EFFECT INCREASED |
2 |
0.0006 |
356 |
ANXIETY |
151 |
0.0006 |
357 |
THERAPEUTIC PRODUCT INEFFECTIVE |
2 |
0.0006 |
358 |
ANGIOPATHY |
3 |
0.0006 |
359 |
METABOLIC DISORDER |
3 |
0.0006 |
360 |
PERIPHERAL COLDNESS |
7 |
0.0006 |
361 |
MEDICATION ERROR |
28 |
0.0006 |
362 |
NIGHTMARE |
18 |
0.0006 |
363 |
CHOLECYSTITIS CHRONIC |
4 |
0.0006 |
364 |
PRODUCT PACKAGING QUANTITY ISSUE |
4 |
0.0006 |
365 |
PALPITATIONS |
58 |
0.0006 |
366 |
PANIC DISORDER |
2 |
0.0006 |
367 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
2 |
0.0006 |
368 |
SOMNOLENCE |
99 |
0.0006 |
369 |
DRUG SCREEN POSITIVE |
4 |
0.0006 |
370 |
PANIC ATTACK |
18 |
0.0006 |
371 |
ARTERIAL THROMBOSIS |
1 |
0.0006 |
372 |
APATHY |
7 |
0.0006 |
373 |
ELECTROCARDIOGRAM ABNORMAL |
4 |
0.0006 |
374 |
APNOEA |
4 |
0.0006 |
375 |
NERVOUSNESS |
27 |
0.0006 |
376 |
INFUSION SITE EXTRAVASATION |
3 |
0.0006 |
377 |
GASTROENTERITIS VIRAL |
8 |
0.0006 |
378 |
HEART RATE INCREASED |
46 |
0.0006 |
379 |
INCONTINENCE |
5 |
0.0006 |
380 |
DROOLING |
3 |
0.0006 |
381 |
FRUSTRATION |
2 |
0.0006 |
382 |
RESPIRATORY RATE INCREASED |
4 |
0.0006 |
383 |
DRUG INEFFECTIVE |
588 |
0.0006 |
384 |
DRUG ADMINISTRATION ERROR |
17 |
0.0006 |
385 |
THIRST |
8 |
0.0006 |
386 |
MIDDLE INSOMNIA |
8 |
0.0005 |
387 |
NECK PAIN |
25 |
0.0005 |
388 |
MENTAL IMPAIRMENT |
11 |
0.0005 |
389 |
BREAST MASS |
3 |
0.0005 |
390 |
POOR VENOUS ACCESS |
4 |
0.0005 |
391 |
APPLICATION SITE DISCOLOURATION |
2 |
0.0005 |
392 |
DYSGRAPHIA |
3 |
0.0005 |
393 |
NERVE COMPRESSION |
4 |
0.0005 |
394 |
AKATHISIA |
6 |
0.0005 |
395 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
3 |
0.0005 |
396 |
CEREBRAL DISORDER |
3 |
0.0005 |
397 |
THERAPY NON-RESPONDER |
16 |
0.0005 |
398 |
INSOMNIA |
117 |
0.0005 |
399 |
SWELLING FACE |
28 |
0.0005 |
400 |
EAR DISORDER |
2 |
0.0005 |
401 |
PRODUCT SOLUBILITY ABNORMAL |
2 |
0.0005 |
402 |
FEEDING DISORDER |
7 |
0.0005 |
403 |
MUSCLE RIGIDITY |
5 |
0.0005 |
404 |
NO ADVERSE EVENT |
61 |
0.0005 |
405 |
FOREIGN BODY |
2 |
0.0005 |
406 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0005 |
407 |
WEIGHT INCREASED |
91 |
0.0005 |
408 |
APPLICATION SITE SCAB |
1 |
0.0005 |
409 |
ADVERSE DRUG REACTION |
33 |
0.0005 |
410 |
THERAPEUTIC RESPONSE SHORTENED |
8 |
0.0005 |
411 |
MULTIPLE ALLERGIES |
3 |
0.0005 |
412 |
APPENDICITIS PERFORATED |
1 |
0.0005 |
413 |
INCORRECT DRUG ADMINISTRATION DURATION |
14 |
0.0005 |
414 |
DRUG DOSE OMISSION BY DEVICE |
11 |
0.0005 |
415 |
IMPAIRED GASTRIC EMPTYING |
3 |
0.0005 |
416 |
PSYCHIATRIC SYMPTOM |
3 |
0.0005 |
417 |
HYPERHIDROSIS |
53 |
0.0005 |
418 |
FEELING HOT |
25 |
0.0005 |
419 |
DYSPHAGIA |
36 |
0.0005 |
420 |
DRY MOUTH |
31 |
0.0005 |
421 |
WHEEZING |
21 |
0.0005 |
422 |
INTENTIONAL SELF-INJURY |
8 |
0.0005 |
423 |
POOR QUALITY DEVICE USED |
3 |
0.0005 |
424 |
APLASTIC ANAEMIA |
2 |
0.0005 |
425 |
FEELING DRUNK |
3 |
0.0005 |
426 |
BODY TEMPERATURE DECREASED |
4 |
0.0005 |
427 |
PRODUCT TASTE ABNORMAL |
5 |
0.0005 |
428 |
VEIN DISORDER |
2 |
0.0005 |
429 |
HEART RATE ABNORMAL |
2 |
0.0005 |
430 |
HUNGER |
4 |
0.0005 |
431 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0005 |
432 |
PRODUCT COMPLAINT |
7 |
0.0005 |
433 |
UNEVALUABLE EVENT |
30 |
0.0005 |
434 |
OSTEOPENIA |
6 |
0.0005 |
435 |
TACHYCARDIA |
33 |
0.0005 |
436 |
INTENTIONAL PRODUCT MISUSE |
32 |
0.0005 |
437 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
68 |
0.0005 |
438 |
ATYPICAL PNEUMONIA |
1 |
0.0005 |
439 |
DIABETIC NEUROPATHY |
2 |
0.0005 |
440 |
PRODUCT SUPPLY ISSUE |
2 |
0.0005 |
441 |
ACTINIC KERATOSIS |
1 |
0.0005 |
442 |
URINARY INCONTINENCE |
11 |
0.0004 |
443 |
POLYURIA |
3 |
0.0004 |
444 |
MOVEMENT DISORDER |
12 |
0.0004 |
445 |
PRODUCT PRESCRIBING ERROR |
7 |
0.0004 |
446 |
FIBROMYALGIA |
8 |
0.0004 |
447 |
APHTHOUS STOMATITIS |
1 |
0.0004 |
448 |
LOSS OF CONSCIOUSNESS |
46 |
0.0004 |
449 |
PRODUCT DISPENSING ERROR |
6 |
0.0004 |
450 |
INTENTIONAL DOSE OMISSION |
5 |
0.0004 |
451 |
PERIPHERAL VASCULAR DISORDER |
2 |
0.0004 |
452 |
ABDOMINAL PAIN UPPER |
70 |
0.0004 |
453 |
SCHIZOPHRENIA |
4 |
0.0004 |
454 |
SKIN WARM |
2 |
0.0004 |
455 |
MENTAL DISORDER |
15 |
0.0004 |
456 |
MIGRAINE |
31 |
0.0004 |
457 |
SKIN HYPERPIGMENTATION |
3 |
0.0004 |
458 |
ALCOHOL ABUSE |
1 |
0.0004 |
459 |
NO THERAPEUTIC RESPONSE |
5 |
0.0004 |
460 |
BRONCHIECTASIS |
2 |
0.0004 |
461 |
JAW DISORDER |
2 |
0.0004 |
462 |
SPINAL OSTEOARTHRITIS |
3 |
0.0004 |
463 |
COORDINATION ABNORMAL |
5 |
0.0004 |
464 |
HYPERVENTILATION |
2 |
0.0004 |
465 |
EAR INFECTION |
8 |
0.0004 |
466 |
NASAL DRYNESS |
2 |
0.0004 |
467 |
DEVICE BREAKAGE |
9 |
0.0004 |
468 |
SLEEP DISORDER |
21 |
0.0004 |
469 |
PRODUCT LABEL ISSUE |
2 |
0.0004 |
470 |
PRODUCT ODOUR ABNORMAL |
3 |
0.0004 |
471 |
ACNE CYSTIC |
1 |
0.0004 |
472 |
HYPERSOMNIA |
9 |
0.0004 |
473 |
ANKLE FRACTURE |
5 |
0.0004 |
474 |
ANOREXIA |
5 |
0.0004 |
475 |
STOMACH DISCOMFORT |
2 |
0.0004 |
476 |
TREMOR |
54 |
0.0004 |
477 |
SKIN LACERATION |
3 |
0.0004 |
478 |
GRANULOCYTOPENIA |
2 |
0.0004 |
479 |
BLOOD PRESSURE INCREASED |
48 |
0.0004 |
480 |
POLLAKIURIA |
13 |
0.0004 |
481 |
UNRESPONSIVE TO STIMULI |
8 |
0.0004 |
482 |
EAR PAIN |
6 |
0.0004 |
483 |
VITAMIN D DEFICIENCY |
3 |
0.0004 |
484 |
ANGIONEUROTIC OEDEMA |
1 |
0.0004 |
485 |
CHEST PAIN |
58 |
0.0004 |
486 |
PRODUCT ADHESION ISSUE |
10 |
0.0004 |
487 |
HEAD DISCOMFORT |
5 |
0.0004 |
488 |
STEVENS-JOHNSON SYNDROME |
7 |
0.0004 |
489 |
DRY THROAT |
3 |
0.0004 |
490 |
PRESYNCOPE |
7 |
0.0004 |
491 |
JOINT DISLOCATION |
3 |
0.0004 |
492 |
ROAD TRAFFIC ACCIDENT |
12 |
0.0004 |
493 |
SEIZURE |
30 |
0.0004 |
494 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0004 |
495 |
DYSARTHRIA |
11 |
0.0003 |
496 |
SINUSITIS |
29 |
0.0003 |
497 |
EMOTIONAL DISTRESS |
39 |
0.0003 |
498 |
WEIGHT DECREASED |
79 |
0.0003 |
499 |
JOINT INJURY |
6 |
0.0003 |
500 |
PRODUCT DOSE OMISSION |
23 |
0.0003 |
501 |
SEROTONIN SYNDROME |
5 |
0.0003 |
502 |
PALLOR |
8 |
0.0003 |
503 |
BODY TEMPERATURE INCREASED |
6 |
0.0003 |
504 |
HAND FRACTURE |
2 |
0.0003 |
505 |
APPLICATION SITE DRYNESS |
1 |
0.0003 |
506 |
MEMORY IMPAIRMENT |
39 |
0.0003 |
507 |
SKIN DISCOLOURATION |
13 |
0.0003 |
508 |
CONFUSIONAL STATE |
46 |
0.0003 |
509 |
SPEECH DISORDER |
15 |
0.0003 |
510 |
SUICIDE ATTEMPT |
17 |
0.0003 |
511 |
DERMATITIS CONTACT |
3 |
0.0003 |
512 |
ABDOMINAL DISTENSION |
28 |
0.0003 |
513 |
INFUSION SITE PAIN |
3 |
0.0003 |
514 |
PRODUCT DOSE OMISSION ISSUE |
48 |
0.0003 |
515 |
VISION BLURRED |
37 |
0.0003 |
516 |
ECONOMIC PROBLEM |
5 |
0.0003 |
517 |
DRUG INTOLERANCE |
25 |
0.0003 |
518 |
WRONG DRUG ADMINISTERED |
3 |
0.0003 |
519 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
520 |
MUSCULAR WEAKNESS |
31 |
0.0003 |
521 |
RASH MACULAR |
9 |
0.0003 |
522 |
BLOOD PRESSURE DIASTOLIC DECREASED |
2 |
0.0003 |
523 |
EXTRASYSTOLES |
2 |
0.0003 |
524 |
DELUSION |
4 |
0.0003 |
525 |
IMMUNOSUPPRESSION |
2 |
0.0003 |
526 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
10 |
0.0003 |
527 |
NAIL DISORDER |
2 |
0.0003 |
528 |
ORAL PAIN |
6 |
0.0003 |
529 |
VENTRICULAR FIBRILLATION |
3 |
0.0003 |
530 |
MACULAR DEGENERATION |
3 |
0.0003 |
531 |
LIPASE INCREASED |
2 |
0.0003 |
532 |
CONDITION AGGRAVATED |
70 |
0.0003 |
533 |
PSEUDOMONAS INFECTION |
2 |
0.0003 |
534 |
ABDOMINAL DISCOMFORT |
41 |
0.0003 |
535 |
VOMITING |
116 |
0.0003 |
536 |
ABNORMAL FAECES |
2 |
0.0003 |
537 |
POOR QUALITY DRUG ADMINISTERED |
2 |
0.0003 |
538 |
PRODUCT ADMINISTRATION ERROR |
4 |
0.0003 |
539 |
EXTRAPYRAMIDAL DISORDER |
7 |
0.0003 |
540 |
WRIST FRACTURE |
3 |
0.0003 |
541 |
EXTRA DOSE ADMINISTERED |
7 |
0.0003 |
542 |
POOR QUALITY SLEEP |
5 |
0.0003 |
543 |
HYPERCHOLESTEROLAEMIA |
2 |
0.0003 |
544 |
GLOSSODYNIA |
5 |
0.0003 |
545 |
SEASONAL ALLERGY |
3 |
0.0003 |
546 |
HYSTERECTOMY |
2 |
0.0003 |
547 |
ACCIDENTAL UNDERDOSE |
2 |
0.0003 |
548 |
CYST |
3 |
0.0003 |
549 |
HEADACHE |
152 |
0.0003 |
550 |
MUSCLE TIGHTNESS |
4 |
0.0003 |
551 |
TREATMENT FAILURE |
18 |
0.0003 |
552 |
KNEE OPERATION |
2 |
0.0003 |
553 |
CROHN'S DISEASE |
2 |
0.0003 |
554 |
MENSTRUAL DISORDER |
2 |
0.0003 |
555 |
ALCOHOL USE |
1 |
0.0003 |
556 |
COMPLICATION OF DEVICE REMOVAL |
3 |
0.0003 |
557 |
DIPLOPIA |
6 |
0.0003 |
558 |
ABDOMINAL ABSCESS |
1 |
0.0003 |
559 |
SCRATCH |
2 |
0.0003 |
560 |
HYPERSENSITIVITY |
43 |
0.0003 |
561 |
HYPOTHYROIDISM |
7 |
0.0003 |
562 |
EYELID OEDEMA |
3 |
0.0003 |
563 |
DYSMENORRHOEA |
3 |
0.0003 |
564 |
HYPOAESTHESIA |
35 |
0.0003 |
565 |
PRODUCT PACKAGING ISSUE |
2 |
0.0003 |
566 |
GASTROOESOPHAGEAL REFLUX DISEASE |
18 |
0.0003 |
567 |
HEMIPLEGIA |
2 |
0.0003 |
568 |
THERAPY CESSATION |
11 |
0.0003 |
569 |
NEPHROLITHIASIS |
10 |
0.0003 |
570 |
VITAMIN D DECREASED |
2 |
0.0003 |
571 |
SCAR |
4 |
0.0003 |
572 |
PARAESTHESIA |
37 |
0.0003 |
573 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
6 |
0.0003 |
574 |
HEAD INJURY |
7 |
0.0003 |
575 |
ROTATOR CUFF SYNDROME |
3 |
0.0003 |
576 |
MUSCLE SPASTICITY |
3 |
0.0003 |
577 |
BLOOD CALCIUM INCREASED |
2 |
0.0003 |
578 |
QUALITY OF LIFE DECREASED |
3 |
0.0003 |
579 |
APPLICATION SITE EXFOLIATION |
1 |
0.0003 |
580 |
RETINAL DETACHMENT |
2 |
0.0003 |
581 |
DERMATITIS ATOPIC |
4 |
0.0003 |
582 |
MUSCLE SPASMS |
41 |
0.0003 |
583 |
SPUTUM DISCOLOURED |
2 |
0.0003 |
584 |
AMNESIA |
15 |
0.0003 |
585 |
INTERVERTEBRAL DISC PROTRUSION |
5 |
0.0003 |
586 |
PURPURA |
2 |
0.0003 |
587 |
DEVELOPMENTAL DELAY |
2 |
0.0003 |
588 |
BLOOD PRESSURE ABNORMAL |
4 |
0.0003 |
589 |
SURGERY |
11 |
0.0003 |
590 |
APPLICATION SITE PAIN |
5 |
0.0003 |
591 |
SYRINGE ISSUE |
3 |
0.0003 |
592 |
URTICARIA |
34 |
0.0003 |
593 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
3 |
0.0003 |
594 |
SKIN FISSURES |
3 |
0.0003 |
595 |
FLANK PAIN |
2 |
0.0003 |
596 |
IRRITABLE BOWEL SYNDROME |
4 |
0.0003 |
597 |
DIZZINESS |
105 |
0.0003 |
598 |
HYPERTENSION |
44 |
0.0003 |
599 |
LUNG INFECTION |
4 |
0.0003 |
600 |
ILL-DEFINED DISORDER |
9 |
0.0003 |
601 |
DEPENDENCE |
2 |
0.0003 |
602 |
SPINAL OPERATION |
2 |
0.0003 |
603 |
MENORRHAGIA |
5 |
0.0003 |
604 |
WEIGHT FLUCTUATION |
2 |
0.0003 |
605 |
DRUG DOSE OMISSION |
42 |
0.0003 |
606 |
PRODUCT PREPARATION ERROR |
3 |
0.0003 |
607 |
ACCIDENTAL OVERDOSE |
7 |
0.0003 |
608 |
INCREASED TENDENCY TO BRUISE |
2 |
0.0003 |
609 |
BACK INJURY |
2 |
0.0003 |
610 |
SALIVARY HYPERSECRETION |
2 |
0.0002 |
611 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
6 |
0.0002 |
612 |
ANAL ABSCESS |
1 |
0.0002 |
613 |
UPPER RESPIRATORY TRACT INFECTION |
9 |
0.0002 |
614 |
HYPOKINESIA |
3 |
0.0002 |
615 |
ABNORMAL DREAMS |
6 |
0.0002 |
616 |
INTENTIONAL PRODUCT USE ISSUE |
16 |
0.0002 |
617 |
MOTOR DYSFUNCTION |
2 |
0.0002 |
618 |
NAUSEA |
154 |
0.0002 |
619 |
HYPOTHERMIA |
2 |
0.0002 |
620 |
ACCIDENTAL EXPOSURE |
1 |
0.0002 |
621 |
INFLUENZA |
20 |
0.0002 |
622 |
INTENTIONAL DRUG MISUSE |
5 |
0.0002 |
623 |
DEFORMITY |
2 |
0.0002 |
624 |
BRONCHITIS |
15 |
0.0002 |
625 |
SLUGGISHNESS |
2 |
0.0002 |
626 |
VIRAL INFECTION |
6 |
0.0002 |
627 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
628 |
HYPOTONIA |
2 |
0.0002 |
629 |
DISORIENTATION |
8 |
0.0002 |
630 |
MALAISE |
86 |
0.0002 |
631 |
PETECHIAE |
2 |
0.0002 |
632 |
UPPER LIMB FRACTURE |
4 |
0.0002 |
633 |
RASH GENERALISED |
6 |
0.0002 |
634 |
PRURITUS GENERALISED |
5 |
0.0002 |
635 |
COUGH |
50 |
0.0002 |
636 |
SWOLLEN TONGUE |
6 |
0.0002 |
637 |
VISUAL ACUITY REDUCED |
7 |
0.0002 |
638 |
APPLICATION SITE BURN |
1 |
0.0002 |
639 |
FISTULA |
2 |
0.0002 |
640 |
FOOT DEFORMITY |
2 |
0.0002 |
641 |
TREATMENT NONCOMPLIANCE |
9 |
0.0002 |
642 |
PRODUCT USE ISSUE |
32 |
0.0002 |
643 |
OFF LABEL USE |
130 |
0.0002 |
644 |
INJECTION SITE URTICARIA |
4 |
0.0002 |
645 |
DRUG LEVEL INCREASED |
3 |
0.0002 |
646 |
NEOPLASM |
2 |
0.0002 |
647 |
PAIN OF SKIN |
5 |
0.0002 |
648 |
CHOLECYSTECTOMY |
2 |
0.0002 |
649 |
DRY EYE |
7 |
0.0002 |
650 |
INCORRECT DOSE ADMINISTERED |
33 |
0.0002 |
651 |
BLINDNESS |
7 |
0.0002 |
652 |
BREAST PAIN |
2 |
0.0002 |
653 |
FEELING COLD |
5 |
0.0002 |
654 |
FATIGUE |
133 |
0.0002 |
655 |
SEXUAL DYSFUNCTION |
2 |
0.0002 |
656 |
ACCIDENT |
2 |
0.0002 |
657 |
HAEMOPTYSIS |
5 |
0.0002 |
658 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
7 |
0.0002 |
659 |
SPINAL PAIN |
2 |
0.0002 |
660 |
LACERATION |
2 |
0.0002 |
661 |
COGNITIVE DISORDER |
8 |
0.0002 |
662 |
DISEASE RECURRENCE |
7 |
0.0002 |
663 |
NASOPHARYNGITIS |
30 |
0.0002 |
664 |
ELECTROCARDIOGRAM QT PROLONGED |
6 |
0.0002 |
665 |
NEURALGIA |
4 |
0.0002 |
666 |
ERYTHEMA |
35 |
0.0002 |
667 |
INJURY |
13 |
0.0002 |
668 |
IMPAIRED DRIVING ABILITY |
2 |
0.0002 |
669 |
CHOLECYSTITIS |
2 |
0.0002 |
670 |
APHAGIA |
1 |
0.0002 |
671 |
ECZEMA |
5 |
0.0002 |
672 |
LYMPHOCYTE COUNT DECREASED |
3 |
0.0002 |
673 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0002 |
674 |
HEART RATE DECREASED |
6 |
0.0002 |
675 |
BLOOD UREA INCREASED |
3 |
0.0002 |
676 |
DIABETIC KETOACIDOSIS |
4 |
0.0002 |
677 |
NEUROLEPTIC MALIGNANT SYNDROME |
2 |
0.0002 |
678 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0002 |
679 |
OSTEOPOROSIS |
7 |
0.0002 |
680 |
HEART RATE IRREGULAR |
4 |
0.0002 |
681 |
VISUAL IMPAIRMENT |
19 |
0.0002 |
682 |
ASTHMA |
16 |
0.0002 |
683 |
LIMB DISCOMFORT |
5 |
0.0002 |
684 |
HERNIA |
3 |
0.0002 |
685 |
PHARYNGEAL OEDEMA |
3 |
0.0002 |
686 |
PRODUCT USE IN UNAPPROVED INDICATION |
32 |
0.0002 |
687 |
ACNE |
13 |
0.0002 |
688 |
RESTLESS LEGS SYNDROME |
3 |
0.0002 |
689 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
7 |
0.0002 |
690 |
CHOKING |
3 |
0.0002 |
691 |
GALLBLADDER DISORDER |
3 |
0.0002 |
692 |
DEVICE ADHESION ISSUE |
2 |
0.0002 |
693 |
DYSURIA |
6 |
0.0002 |
694 |
ANAPHYLACTIC REACTION |
8 |
0.0002 |
695 |
CONTUSION |
15 |
0.0002 |
696 |
PHARMACEUTICAL PRODUCT COMPLAINT |
5 |
0.0002 |
697 |
DRUG EFFECT INCOMPLETE |
7 |
0.0002 |
698 |
PHARYNGITIS |
2 |
0.0002 |
699 |
LIBIDO DECREASED |
2 |
0.0002 |
700 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
701 |
SKIN EXFOLIATION |
12 |
0.0002 |
702 |
DRUG WITHDRAWAL SYNDROME |
16 |
0.0002 |
703 |
NODULE |
2 |
0.0002 |
704 |
TENDON RUPTURE |
2 |
0.0002 |
705 |
DISABILITY |
3 |
0.0002 |
706 |
FOOT FRACTURE |
3 |
0.0002 |
707 |
BLOOD CHOLESTEROL INCREASED |
7 |
0.0002 |
708 |
SINUS DISORDER |
3 |
0.0002 |
709 |
EXPIRED PRODUCT ADMINISTERED |
5 |
0.0002 |
710 |
FUNGAL INFECTION |
5 |
0.0002 |
711 |
COMPLICATION ASSOCIATED WITH DEVICE |
2 |
0.0002 |
712 |
BEDRIDDEN |
2 |
0.0002 |
713 |
LIP SWELLING |
5 |
0.0002 |
714 |
MUSCULOSKELETAL DISORDER |
3 |
0.0002 |
715 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
13 |
0.0002 |
716 |
GAIT INABILITY |
4 |
0.0002 |
717 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
718 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0002 |
719 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0002 |
720 |
CLOSTRIDIUM DIFFICILE INFECTION |
3 |
0.0002 |
721 |
SINUS CONGESTION |
2 |
0.0002 |
722 |
SYNCOPE |
15 |
0.0002 |
723 |
DEVICE ISSUE |
11 |
0.0002 |
724 |
EPISTAXIS |
11 |
0.0002 |
725 |
CONTRAINDICATED PRODUCT ADMINISTERED |
4 |
0.0002 |
726 |
ASTHENIA |
54 |
0.0002 |
727 |
DRY SKIN |
17 |
0.0002 |
728 |
RESPIRATORY DISTRESS |
4 |
0.0002 |
729 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
730 |
INJECTION SITE EXTRAVASATION |
2 |
0.0002 |
731 |
DYSPHONIA |
8 |
0.0002 |
732 |
UNDERDOSE |
10 |
0.0002 |
733 |
MASS |
2 |
0.0002 |
734 |
EPILEPSY |
4 |
0.0002 |
735 |
ARTHROPOD BITE |
1 |
0.0002 |
736 |
TOXICITY TO VARIOUS AGENTS |
22 |
0.0002 |
737 |
DYSPNOEA |
77 |
0.0002 |
738 |
PARALYSIS |
2 |
0.0002 |
739 |
BLOOD PRESSURE DECREASED |
9 |
0.0002 |
740 |
RESPIRATORY DISORDER |
4 |
0.0002 |
741 |
INJECTION SITE BRUISING |
10 |
0.0002 |
742 |
ANHEDONIA |
4 |
0.0002 |
743 |
NEUTROPHIL COUNT DECREASED |
5 |
0.0002 |
744 |
CONSTIPATION |
27 |
0.0002 |
745 |
IMPAIRED WORK ABILITY |
3 |
0.0002 |
746 |
THYROID DISORDER |
2 |
0.0002 |
747 |
NEEDLE ISSUE |
3 |
0.0002 |
748 |
APPLICATION SITE RASH |
2 |
0.0002 |
749 |
CARDIOMYOPATHY |
2 |
0.0002 |
750 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
17 |
0.0002 |
751 |
RHINORRHOEA |
8 |
0.0002 |
752 |
HYPOAESTHESIA ORAL |
2 |
0.0002 |
753 |
NIGHT SWEATS |
4 |
0.0002 |
754 |
RASH |
54 |
0.0002 |
755 |
TOOTH DISORDER |
3 |
0.0002 |
756 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0002 |
757 |
CHROMATURIA |
3 |
0.0002 |
758 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
4 |
0.0002 |
759 |
BRADYCARDIA |
7 |
0.0002 |
760 |
ASPHYXIA |
1 |
0.0002 |
761 |
WHITE BLOOD CELL COUNT INCREASED |
5 |
0.0002 |
762 |
GENERAL PHYSICAL HEALTH DETERIORATION |
13 |
0.0002 |
763 |
SKIN IRRITATION |
6 |
0.0002 |
764 |
INCORRECT PRODUCT STORAGE |
2 |
0.0002 |
765 |
SKIN BURNING SENSATION |
9 |
0.0002 |
766 |
APPLICATION SITE REACTION |
1 |
0.0002 |
767 |
DEVICE RELATED INFECTION |
2 |
0.0002 |
768 |
BONE LOSS |
2 |
0.0001 |
769 |
BACK DISORDER |
2 |
0.0001 |
770 |
GASTROINTESTINAL DISORDER |
9 |
0.0001 |
771 |
PYREXIA |
42 |
0.0001 |
772 |
OROPHARYNGEAL PAIN |
11 |
0.0001 |
773 |
CHEST DISCOMFORT |
12 |
0.0001 |
774 |
PAIN |
76 |
0.0001 |
775 |
DRUG TOXICITY |
2 |
0.0001 |
776 |
STOMATITIS |
7 |
0.0001 |
777 |
BLOOD PRESSURE FLUCTUATION |
3 |
0.0001 |
778 |
OCULAR HYPERAEMIA |
5 |
0.0001 |
779 |
EXPOSURE DURING PREGNANCY |
7 |
0.0001 |
780 |
GASTRIC DISORDER |
5 |
0.0001 |
781 |
GAIT DISTURBANCE |
23 |
0.0001 |
782 |
COLITIS |
4 |
0.0001 |
783 |
INTENTIONAL OVERDOSE |
7 |
0.0001 |
784 |
RASH PRURITIC |
6 |
0.0001 |
785 |
STAPHYLOCOCCAL INFECTION |
4 |
0.0001 |
786 |
SENSORY DISTURBANCE |
2 |
0.0001 |
787 |
PRODUCTIVE COUGH |
5 |
0.0001 |
788 |
STRESS |
8 |
0.0001 |
789 |
MOBILITY DECREASED |
8 |
0.0001 |
790 |
PROCEDURAL PAIN |
3 |
0.0001 |
791 |
APPENDICITIS |
1 |
0.0001 |
792 |
PHOTOPHOBIA |
2 |
0.0001 |
793 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
794 |
BALANCE DISORDER |
10 |
0.0001 |
795 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
796 |
VERTIGO |
7 |
0.0001 |
797 |
BLISTER |
6 |
0.0001 |
798 |
OVERDOSE |
24 |
0.0001 |
799 |
HEMIPARESIS |
2 |
0.0001 |
800 |
ACCIDENTAL EXPOSURE TO PRODUCT |
8 |
0.0001 |
801 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
802 |
ALANINE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
803 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
804 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
805 |
EYE SWELLING |
4 |
0.0001 |
806 |
DEHYDRATION |
15 |
0.0001 |
807 |
THROAT TIGHTNESS |
3 |
0.0001 |
808 |
ANURIA |
1 |
0.0001 |
809 |
FALL |
36 |
0.0001 |
810 |
ABDOMINAL PAIN |
25 |
0.0001 |
811 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
812 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
813 |
DEVICE LEAKAGE |
3 |
0.0001 |
814 |
INJECTION SITE HAEMORRHAGE |
8 |
0.0001 |
815 |
LUNG DISORDER |
5 |
0.0001 |
816 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
817 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
818 |
THERAPEUTIC RESPONSE DECREASED |
6 |
0.0001 |
819 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
820 |
INFLUENZA LIKE ILLNESS |
9 |
0.0001 |
821 |
GLAUCOMA |
2 |
0.0001 |
822 |
MENSTRUATION IRREGULAR |
3 |
0.0001 |
823 |
BACK PAIN |
24 |
0.0001 |
824 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0001 |
825 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
826 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
827 |
BONE DISORDER |
2 |
0.0001 |
828 |
ABORTION INDUCED |
1 |
0.0001 |
829 |
DIABETES MELLITUS |
8 |
0.0001 |
830 |
DYSSTASIA |
3 |
0.0001 |
831 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
4 |
0.0001 |
832 |
ABASIA |
3 |
0.0001 |
833 |
DEEP VEIN THROMBOSIS |
7 |
0.0001 |
834 |
MOUTH ULCERATION |
2 |
0.0001 |
835 |
RIB FRACTURE |
2 |
0.0001 |
836 |
OXYGEN SATURATION DECREASED |
5 |
0.0001 |
837 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
838 |
CELLULITIS |
5 |
0.0001 |
839 |
ASPIRATION |
1 |
0.0001 |
840 |
ABORTION SPONTANEOUS |
4 |
0.0001 |
841 |
METRORRHAGIA |
2 |
0.0001 |
842 |
RHABDOMYOLYSIS |
4 |
0.0001 |
843 |
INFECTION |
13 |
0.0001 |
844 |
IMPAIRED HEALING |
3 |
0.0001 |
845 |
DRUG HYPERSENSITIVITY |
19 |
0.0001 |
846 |
INJECTION SITE PAIN |
26 |
0.0001 |
847 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
848 |
EYE DISORDER |
3 |
0.0001 |
849 |
DRUG INTERACTION |
15 |
0.0001 |
850 |
HEPATIC ENZYME INCREASED |
6 |
0.0001 |
851 |
WHITE BLOOD CELL COUNT DECREASED |
10 |
0.0001 |
852 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
853 |
PRURITUS |
31 |
0.0001 |
854 |
THROAT IRRITATION |
4 |
0.0001 |
855 |
FLUSHING |
10 |
0.0001 |
856 |
PANCREATITIS ACUTE |
2 |
0.0001 |
857 |
NASAL CONGESTION |
5 |
0.0001 |
858 |
DEVICE DISLOCATION |
4 |
0.0001 |
859 |
URINARY RETENTION |
3 |
0.0001 |
860 |
BACTERAEMIA |
1 |
0.0001 |
861 |
TOOTH LOSS |
2 |
0.0001 |
862 |
CYSTITIS |
3 |
0.0001 |
863 |
TYPE 2 DIABETES MELLITUS |
3 |
0.0001 |
864 |
CHOLELITHIASIS |
3 |
0.0001 |
865 |
PREGNANCY |
2 |
0.0001 |
866 |
PSORIATIC ARTHROPATHY |
3 |
0.0001 |
867 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
868 |
ARTHRALGIA |
35 |
0.0001 |
869 |
ADVERSE EVENT |
8 |
0.0001 |
870 |
COVID-19 |
13 |
0.0001 |
871 |
INJECTION SITE MASS |
3 |
0.0001 |
872 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
873 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
3 |
0.0001 |
874 |
DEVICE MALFUNCTION |
5 |
0.0001 |
875 |
RASH PAPULAR |
2 |
0.0001 |
876 |
CHILLS |
10 |
0.0001 |
877 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
878 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
2 |
0.0001 |
879 |
PAIN IN EXTREMITY |
25 |
0.0001 |
880 |
MYALGIA |
14 |
0.0001 |
881 |
HOSPITALISATION |
11 |
0.0001 |
882 |
EYE PAIN |
4 |
0.0001 |
883 |
HYPERGLYCAEMIA |
3 |
0.0001 |
884 |
MULTIPLE SCLEROSIS |
4 |
0.0001 |
885 |
MUSCULOSKELETAL STIFFNESS |
7 |
0.0001 |
886 |
ERECTILE DYSFUNCTION |
2 |
0.0001 |
887 |
MULTIPLE SCLEROSIS RELAPSE |
6 |
0.0001 |
888 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
889 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
890 |
LIMB INJURY |
2 |
0.0001 |
891 |
PNEUMONIA |
24 |
0.0001 |
892 |
ARTHRITIS |
6 |
0.0001 |
893 |
OEDEMA PERIPHERAL |
10 |
0.0001 |
894 |
SKIN ULCER |
2 |
0.0001 |
895 |
ADVERSE REACTION |
1 |
0.0001 |
896 |
THERAPY INTERRUPTED |
3 |
0.0001 |
897 |
SKIN LESION |
2 |
0.0001 |
898 |
JOINT STIFFNESS |
2 |
0.0001 |
899 |
APHONIA |
1 |
0.0001 |
900 |
GASTRITIS |
2 |
0.0001 |
901 |
HYPOACUSIS |
3 |
0.0001 |
902 |
PANCREATITIS |
4 |
0.0001 |
903 |
DISCOMFORT |
4 |
0.0001 |
904 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
905 |
INJECTION SITE REACTION |
5 |
0.0001 |
906 |
EYE PRURITUS |
2 |
0.0001 |
907 |
HOT FLUSH |
5 |
0.0001 |
908 |
ARTHROPATHY |
4 |
0.0001 |
909 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
910 |
JAUNDICE |
2 |
0.0001 |
911 |
DIARRHOEA |
42 |
0.0001 |
912 |
PAIN IN JAW |
2 |
0.0001 |
913 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
0.0001 |
914 |
URINARY TRACT INFECTION |
11 |
0.0001 |
915 |
HYPOKALAEMIA |
3 |
0.0001 |
916 |
PLATELET COUNT DECREASED |
7 |
0.0001 |
917 |
RESPIRATORY ARREST |
2 |
0.0001 |
918 |
TINNITUS |
3 |
0.0001 |
919 |
ANGINA PECTORIS |
2 |
0.0001 |
920 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
921 |
HYPOTENSION |
13 |
0.0001 |
922 |
APHASIA |
2 |
0.0001 |
923 |
PREMATURE BABY |
2 |
0.0001 |
924 |
RENAL DISORDER |
3 |
0.0001 |
925 |
ACUTE MYOCARDIAL INFARCTION |
2 |
0.0001 |
926 |
RHEUMATOID ARTHRITIS |
7 |
0.0001 |
927 |
ABSCESS |
1 |
0.0001 |
928 |
INFLAMMATION |
3 |
0.0001 |
929 |
DYSGEUSIA |
5 |
0.0001 |
930 |
SKIN DISORDER |
2 |
0.0001 |
931 |
DYSPEPSIA |
6 |
0.0001 |
932 |
CARDIAC DISORDER |
6 |
0.0001 |
933 |
COMA |
3 |
0.0001 |
934 |
PSORIASIS |
8 |
0.0001 |
935 |
ARRHYTHMIA |
3 |
0.0001 |
936 |
DELIRIUM |
2 |
0.0001 |
937 |
CHRONIC KIDNEY DISEASE |
5 |
0.0001 |
938 |
CARDIAC ARREST |
5 |
0.0001 |
939 |
CORONARY ARTERY DISEASE |
2 |
0.0001 |
940 |
BONE DENSITY DECREASED |
2 |
0.0001 |
941 |
BACTERIAL INFECTION |
1 |
0.0001 |
942 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
943 |
BLOOD GLUCOSE INCREASED |
11 |
0.0001 |
944 |
BURNING SENSATION |
4 |
0.0001 |
945 |
SWELLING |
5 |
0.0001 |
946 |
ALOPECIA |
11 |
0.0001 |
947 |
COLITIS ULCERATIVE |
2 |
0.0001 |
948 |
FLATULENCE |
3 |
0.0001 |
949 |
DRUG DEPENDENCE |
10 |
0.0001 |
950 |
HERPES ZOSTER |
3 |
0.0001 |
951 |
PRODUCT STORAGE ERROR |
3 |
0.0001 |
952 |
PULMONARY EMBOLISM |
5 |
0.0001 |
953 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0001 |
954 |
DRUG EXPOSURE DURING PREGNANCY |
2 |
0.0001 |
955 |
DEVICE DIFFICULT TO USE |
2 |
0.0001 |
956 |
LIVER DISORDER |
2 |
0.0001 |
957 |
DISEASE PROGRESSION |
5 |
0.0001 |
958 |
RECTAL HAEMORRHAGE |
2 |
0.0001 |
959 |
CEREBROVASCULAR ACCIDENT |
8 |
0.0001 |
960 |
VAGINAL HAEMORRHAGE |
2 |
0.0001 |
961 |
JOINT SWELLING |
5 |
0.0001 |
962 |
INJECTION SITE SWELLING |
3 |
0.0001 |
963 |
DEVICE EXPULSION |
3 |
0.0001 |
964 |
ANAPHYLACTIC SHOCK |
1 |
0.0001 |
965 |
PERIPHERAL SWELLING |
6 |
0.0001 |
966 |
MYOCARDIAL INFARCTION |
8 |
0.0001 |
967 |
LEUKOPENIA |
2 |
0.0001 |
968 |
ATRIAL FIBRILLATION |
4 |
0.0001 |
969 |
HYPOGLYCAEMIA |
2 |
0.0000 |
970 |
AGEUSIA |
1 |
0.0000 |
971 |
HAEMORRHAGE |
4 |
0.0000 |
972 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
973 |
FLUID RETENTION |
2 |
0.0000 |
974 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
975 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
976 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
977 |
OEDEMA |
2 |
0.0000 |
978 |
THROMBOSIS |
3 |
0.0000 |
979 |
ANAEMIA |
7 |
0.0000 |
980 |
CATARACT |
2 |
0.0000 |
981 |
DRUG ABUSE |
3 |
0.0000 |
982 |
HYPONATRAEMIA |
2 |
0.0000 |
983 |
RENAL FAILURE |
5 |
0.0000 |
984 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
985 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
986 |
BONE PAIN |
2 |
0.0000 |
987 |
COMPLETED SUICIDE |
3 |
0.0000 |
988 |
RESPIRATORY FAILURE |
2 |
0.0000 |
989 |
CARDIAC FAILURE |
2 |
0.0000 |
990 |
RENAL IMPAIRMENT |
2 |
0.0000 |
991 |
ANGIOEDEMA |
1 |
0.0000 |
992 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
993 |
THROMBOCYTOPENIA |
2 |
0.0000 |
994 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
995 |
NEUTROPENIA |
2 |
0.0000 |
996 |
DEATH |
11 |
0.0000 |